Machine-Learning-based Prediction of Sepsis Events from Vertical Clinical Trial Data: a Naïve Approach by Gaddis, Tyler Michael
University of Wisconsin Milwaukee 
UWM Digital Commons 
Theses and Dissertations 
August 2020 
Machine-Learning-based Prediction of Sepsis Events from 
Vertical Clinical Trial Data: a Naïve Approach 
Tyler Michael Gaddis 
University of Wisconsin-Milwaukee 
Follow this and additional works at: https://dc.uwm.edu/etd 
 Part of the Biostatistics Commons, Computer Sciences Commons, and the Health Services 
Administration Commons 
Recommended Citation 
Gaddis, Tyler Michael, "Machine-Learning-based Prediction of Sepsis Events from Vertical Clinical Trial 
Data: a Naïve Approach" (2020). Theses and Dissertations. 2752. 
https://dc.uwm.edu/etd/2752 
This Thesis is brought to you for free and open access by UWM Digital Commons. It has been accepted for 
inclusion in Theses and Dissertations by an authorized administrator of UWM Digital Commons. For more 
information, please contact scholarlycommunicationteam-group@uwm.edu. 
MACHINE-LEARNING-BASED SEPSIS PREDICTION USING VERTICAL CLINICAL TRIAL DATA:  








A Thesis Submitted in  
Partial Fulfillment of the 
Requirements for the Degree of 
 
Master of Science  
in Health Care Informatics 
 
at 





MACHINE-LEARNING-BASED SEPSIS PREDICTION USING VERTICAL CLINICAL TRIAL DATA: 







The University of Wisconsin – Milwaukee, 2020 
Under the Supervision of Jake Luo, PhD 
 
 
Sepsis is a potentially life-threatening condition characterized by a dysregulated, 
disproportionate immune response to infection by which the afflicted body attacks its own 
tissues, sometimes to the point of organ failure, and in the worst cases, death.  According to 
the Centers for Disease Control and Prevention (CDC) Sepsis is reported to kill upwards of 
270,000 Americans annually, though this figure may be greater given certain ambiguities in the 
current accepted diagnostic framework of the disease.  
This study attempted to first establish an understanding of past definitions of sepsis, 
and to then recommend use of machine learning as integral in an eventual amended disease 
definition. Longitudinal clinical trial data (ntrials=30,915) were vectorized into a machine-
readable format compatible with predictive modeling, selected and reduced in dimension, and 
used to predict incidences of sepsis via application of several machine learning models: logistic 
regression, support vector machines (SVM), naïve Bayes Classifier, decision trees, and random 
forests. The intent of the study was to identify possible predictive features for sepsis via 
comparative analysis of different machine learning models, and to recommend subsequent 
study of sepsis prediction using the training model on new data (non-clinical-trial-derived) in 
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the same format. If the models can be generalized to new data, it stands to assume they could 
eventually become clinically useful. In referencing F1 scores and recall scores, the random 
forest classifier was the best performer among this cohort of models. 
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Sepsis is a clinical syndrome of exaggerated and life-threatening systemic immune 
responses launched by the body against its own tissues on encountering an infection ultimately 
resulting in organ damage, organ failure, or death. It is a syndrome comprising myriad 
combinations of clinical symptoms in patients suffering from infection, rendering its precise 
pathophysiologic definition and subsequent treatment elusive and tenuous at best (Singer et 
al., 2016). No single system, pathogen, mediator, or pathway have been isolated as preeminent 
drivers of sepsis pathophysiology (Remick, 2007). Sepsis diagnosis is made ambiguous due to its 
shared symptoms with other comorbidity pathophysiologies, and modern pervasive use of 
antibiotics producing false negative culture results (Vincent, 2016).  
The urgency of sepsis and a valid sepsis diagnostic tool is underscored by several facts: that 
all of the body’s organ systems are susceptible to it; that the only requirement for sepsis onset 
is bacterial, viral, fungal, or parasitic infection; that its frequency is increasing due to an aging 
population long benefitting from chronic condition management (here it is hypothesized that 
the conditions being managed may be predictive factors for sepsis); that until a 2016 task force 
that redefined criteria for sepsis (Sepsis-3), the syndrome definition was over-reliant on 
inflammation as its baseline assessment criterion, and on a misguided spectrum model of 
disease (Singer et al., 2016); that up to and beyond this task force the definition lacked general 
consensus pertaining to its usefulness for clinical diagnosis versus prognosis; that a 
demonstrable heterogeneity of inflammatory response and cellular changes in organ tissues of 
septic patients exists (Remick, 2007), and thus, that sepsis can initially be clinically 
indistinguishable from systemic inflammation from non-infectious causes (Lopansri, Miller, & 
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Brandon, 2019); that survivors of sepsis remain susceptible to subsequent chronic physiological, 
psychological and cognitive ailments. 
Because sepsis represents a relatively common but acute and often lethal clinical syndrome, 
continued efforts must be leveraged to identify its precise etiology and pathophysiology. As a 
contribution to this effort, this case study attempts to identify predictors for sepsis from a large 
clinical trial dataset (n = 30,915) in the form of severe and less-severe adverse events, trial 
stage, preexisting conditions, and interventions used for trial health outcomes. If comorbidities 
of sepsis are isolated in a large enough sample size, it could be argued that sepsis ought to be 
treated according to site-specific biomarkers of, conditions of, and/or proximity to organ 
systems where the syndrome develops. 
 
1.1. RELEVANT SEPSIS STATISTICS 
Sepsis represents a significant tax on the American healthcare infrastructure and deserves a 
corresponding magnitude of attention. In 2013 alone, sepsis accounted for $24 billion of total 
US hospital costs (Paoli et al., 2018). One two-cohort study (Kaiser Permanente Northern 
California, n=482,828; Healthcare Cost and Utilization Project Nationwide Inpatient Sample, 
n=6,500,000) found that upwards of 50% of all hospital deaths are attributable to sepsis (Liu et 
al., 2014).  
According to the CDC (Centers for Disease Control and Prevention), 1.7 million American 
adults develop sepsis annually, 270,000 of whom die from the disease, amounting to a 
mortality rate of nearly 16% (Centers for Disease Control and Prevention, 2020). Sepsis is most 
commonly seen in adults aged 65 or older, immunocompromised and chronically ill patients, 
3 
and in infants. Signs and symptoms include tachycardia, disorientation/confusion, discomfort, 
fever or hypothermia, dyspnea, and perspiration.  
 
1.2. SEPSIS: A FORMAL DEFINITION 
Sepsis has been in the medical consciousness for millennia and has been formally defined 
several times. Louis Pasteur’s germ theory of disease attributed infection to harmful microbes, 
thus spurring the first science-derived, empirically driven pursuit of sepsis comprehension. The 
first modern definition of sepsis, posited by Hugo Schottmüller in 1914, was than more modern 
definitions:  
Sepsis is present if a focus has developed from which pathogenic bacteria, constantly or 
periodically, invade the blood stream in such a way that this causes subjective and objective 
symptoms. 
(Gyawali et al., 2019) 
 
 More specifically, its definition has evolved as the pathophysiology of the syndrome and 
pathobiology of affected tissues have enjoyed greater understanding. Subsequent official 
definitions followed Schottmüller’s, most notably Sepsis-1, Sepsis-2, and Sepsis-3. 
1.2.1. Sepsis-1 
In 1991 the first consensus definition of sepsis was established at an American College 
of Chest Physicians-Society of Critical Care Medicine (ACCP-SCCM) conference helmed by Roger 
Bone. Bone made an argument for the improved definition of sepsis, and the importance of 
precision of language in defining it (Bone, 1991). According to the proposed definition, sepsis 
was a spectrum of systemic responses to infection ranging from systemic inflammatory 
response syndrome (SIRS), to severe sepsis (sepsis complicated by organ dysfunction), to septic 
shock (“sepsis-induced hypotension persisting despite adequate fluid resuscitation”) (Bone et 
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al., 1992). SIRS was the first of these stages of sepsis and so a definition considering the host’s 
inflammatory response to infection as its foundational attribute followed. Sepsis-1 was ideally 
framed to treat sepsis and SIRS as non-disjoint systemic responses to environmental factors 
including but not limited to infection (Bone et al., 1992). 
 
Table 1. SIRS Criteria 
 
(Carneiro, Povoa, & Gomes, 2017) 
 
Figure 1. SIRS, Sepsis, and Infection Venn Diagram 
(Bone et al., 1992) 
 
Four SIRS criteria were established: tachycardia (resting heart rate of over 90 beats per 
minute), tachypnea (respiration rate of over 20 times per minute), body core temperature 
dysregulation (fever: core temperature above 38°C; hypothermia: core temperature below 
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36°C), and leukocytosis, leukopenia, or bandemia (leukocytes in greater concentrations than 
1200/mm3, leukocytes in lower concentrations than 4000/mm3, or bandemia of ≥10%m, 
respectively). The 1991 convention asserts that to be clinically diagnosed as SIRS-positive, 
patients must exhibit two or more of these criteria (Marik and Taeb, 2017).  
But the SIRS criteria proved to be far too general. If any two of the four SIRS criteria 
were observed in patients, SIRS criteria were theoretically met, and thus the first “stage” of 
sepsis would have been recorded as observed in such patients. For example, on average, up to 
90% of intensive care unit (ICU) patients exhibit symptoms meeting SIRS criteria, to the extent 
that they are eligible for sepsis diagnosis according to the Sepsis-1-SIRS criteria (Sprung et al., 
2006). Given that most infections induce some form of SIRS criteria (for example, tachycardia, 
fever, high leukocyte counts) yet such infections less often result in actual recorded incidence 
of sepsis (in the most relevant definition’s sense of the word), Sepsis-1 and its heavy reliance on 
SIRS criteria represents a mischaracterization of infection and inflammation as sepsis. A new 
definition was need. 
1.2.2. Sepsis-2 
In 2001, a task force met to address the limitations of the Sepsis-1 definition, and in so 
doing attempted a reformed definition of sepsis, later coined “Sepsis-2” by the Journal of the 
American Medical Association in 2016. The task force at the 2001 consensus conference sought 
a more precise definition of sepsis via a thorough consideration of all clinical factors associated 
with it. But what was intended as a conference to reform the definition of sepsis as a condition 
commensurate with a few comorbidities resulted in loss of specificity and clarity as to what 
constituted the condition. The Sepsis-2 baseline criterium was infection, included the four SIRS 
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criteria from Sepsis-1, and several coinciding SIRS-related symptoms. These other symptoms 
were grouped by “general parameters”, “inflammatory parameters”, “hemodynamic 
parameters”, “tissue perfusion parameters”, and “organ dysfunction parameters”, and are 
summarized in the following table:  
 
Table 2. Sepsis-2 Criteria 
   
(Carneiro, Povoa, & Gomes, 2017) 
Though intended as a comprehensive reference for indicators of sepsis, many of the 
criteria from this list were consistent with normal immune responses to infection. Despite its 
intention for specificity, it broadened the scope of symptoms and subsequently was in danger 
of identifying infection paired with any of the listed comorbidities as proxies for sepsis. To that 
end, the conference was considered a failure, and Sepsis-1 persisted as the most relevant 
definition for sepsis (Vincent, et al., 2013). Between 2001 and 2016 (Sepsis-3), advances in 
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understanding of sepsis pathophysiology, etiology, pathobiology, and immunology were made, 
which merited a new definition for the condition.  
 
1.2.3. Sepsis-3 
In 2016 the Journal of the American Medical Association (JAMA) proposed a third definition 
of Sepsis that abandoned an argued overreliance on SIRS/inflammation, and instead opted to 
treat the syndrome not as a continuum, but as a “life-threatening organ dysfunction caused by 
a dysregulated host response to infection” (Singer et al., 2016). More specifically this definition 
attempts to discriminate between past notions of sepsis and non-sepsis-related infection, to 
account for pro- and anti-inflammatory responses associated with sepsis (which otherwise 
would have been confounding, given previous definition’s reliance on inflammation/SIRS 
criteria), and to establish the “primacy of the nonhomeostatic host response to infection, the 
potential lethality that is considerably in excess of a straightforward infection, and the need for 
urgent recognition” (Singer et al., 2016). This definition is argued to be the most and accurate 
and practical addendum to AMA-sanctioned formal sepsis definitions because it accounts for 
modern conventional wisdom while yielding that less understood influences (e.g. genetic or 
cellular influences) could yet impact sepsis pathophysiology and pathobiology. In addition, the 
definition was designed to address severe variations in sepsis incidence and mortality 
attributed to a lack of standardized definitions for sepsis and septic shock. (Singer et al., 2016) 
By restructuring and reforming the existing sepsis framework to instead focus on infection, 
host response, and organ dysfunction, JAMA cited an improved understanding of pathobiology 
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(“organ function, morphology, cell biology, biochemistry, immunology and circulation”) as the 
chief impetus for its revision (Singer et al., 2016). 
Because this definition rejected the limited emphasis on inflammation placed by the Sepsis-
1 and Sepsis-2 definitions, new criteria constituting sepsis and septic shock were required.  
Given that sepsis phenotypes differ across patient populations manifesting a range of 
different comorbidities, interventions, and infections, a broader understanding of sepsis was 
pursued. In response to this need, the 2016 task force suggested largely abandoning SIRS 
criteria in favor of the Sepsis-related Organ Failure Assessment (SrOFA), renamed the 
Sequential Organ Failure Assessment (SOFA) as primary criteria for diagnosis. SOFA criteria 
were designed to identify signs of all previously identified sepsis symptoms, namely “infection, 
host response, and organ dysfunction”. Under these guidelines, if a patient presents with a 
SOFA score greater than 2, they are immediately assigned a 10% mortality risk to emphasize the 
need for expedient treatment (even if symptom acuity has yet to manifest/rise). (Singer et al., 
2016) 
A bedside SOFA inventory for patients already presenting with more acute symptoms 
consistent with sepsis was also created. This quick SOFA survey, or qSOFA, has three criteria: 
altered mental status, systolic blood pressure ≥ 100 mmHg, and respiratory rate ≥ 22 per 
minute. Using qSOFA, patients meeting any two of these three criteria yielded a predictive 
validity of 55% in accurately identifying sepsis. For this reason, qSOFA is suggested by Singer 
and colleagues as an adequate tool for establishing whether subsequent investigation of 
patient symptoms perhaps consistent with sepsis is necessary.  Moreover, qSOFA requires no 
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lab analyses, making it an expedient, cheap, abridged alternative to an initial, more invasive, 
and expensive SOFA assessment. (Singer et al., 2016) 
Despite the shift to SOFA/qSOFA, a noncontroversial consensus definition for sepsis remains 
unfulfilled. The 2016 conference conceded that a consolidated, simple definition of sepsis was a 
lofty goal, given the understanding of etiologic-specific pathophysiology and pathobiology of 
individual sepsis incidences. The task force charged with pursuing this goal instead offered a 
prognostic tool for subsequent testing if either a. a patient presented with infection and was 
already suspected sepsis-positive, or b., a patient exhibited any two of the three qSOFA criteria 
indicating significant likelihood of mortality absent a health intervention. 
 
1.3 A Critique of the 2016 Sepsis Definition  
 
Though the authors’ intentions behind establishing tools for outcome prediction associated 
with sepsis were good, and though the SOFA/qSOFA scoring systems proved useful tools in a 
prognostic sense, the authors failed to propose a new and valid sepsis diagnostic tool and 
definition. In the authors’ own words: 
The agreement between potential clinical criteria (construct validity) and the ability of the 
criteria to predict outcomes typical of sepsis, such as need for intensive care unit (ICU) 
admission or death (predictive validity, a form of criterion validity), were then tested. 
 
(Singer et al., 2017) 
 
This statement suggests that the aim of the qSOFA/SOFA tools was for outcome prediction on 
encountering symptoms consistent with sepsis. The proposed diagnostic framework was less of 
a valid proposal for establishing a systematic diagnostic decision algorithm, and more a critique 
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of a past overreliance on inflammation as a valid metric for sepsis. Semantics were modified to 
eliminate “severe sepsis” as clinically distinguishable from “sepsis”. 
 The reason that this is a substantive argument against the current Sepsis-3 framework 
(and for an alternative model) is because clinicians in the intensive care unit (ICU) are tasked 
with maximizing healthcare outcomes of unstable, acutely sick patients population. This, in 
contrast with emergency department (ED) clinicians’ responsibilities for health diagnoses and 
treatment, represents a discrepancy in the intended changes proposed by the Sepsis-3 
framework from its predecessors. Moreover, qSOFA and SOFA are recorded as having been 
validated in an ICU-environment; but sepsis is not limited to the ICU. Prognosis cannot be 
equated with diagnosis. Effect does not equal cause. 
 Because medically applied machine learning models and clinical decision support tools 
are becoming increasingly ubiquitous in the clinical space and given the heavy burden that  
sepsis represents to the American healthcare system, integration of relevant machine learning 
models with existing and legacy sepsis diagnostic models deserves serious and immediate 
attention. Rather than using solely Sepsis-3, clinician gestalt, and electronic health record (EHR) 
maintained patient health history, the current sepsis diagnostic framework deserves an update. 
Machine learning can be leveraged to augment the current model of sepsis via comorbidity 
identification, and ideally, to offer organ-system-specific/context-specific sepsis ‘strain’ 
diagnosis.  
Where symptom-non-disjointness can make sepsis diagnosis convoluted and intangible, 
machine learning can rectify this issue. Machine learning can augment conventional wisdom via 
robust calculation of probabilities of disease given the presence or absence of specific features. 
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Such features are limitless: age, sex, weight, blood pressure, health history, family health 
history, active comorbidities, living situations, active medications, etcetera. Machine learning 
thus represents a modern tool capable of delivering the intended outcomes of evidence-based 
medicine.  
This argument is admittedly neither radical nor new. However, the reform of a 
consensus definition with one that integrates machine learning into its methodology is less 
common. Existing predictive analyses for sepsis are predicated on conventional wisdom 
established by criteria outlined in any one of the three modern definitions for sepsis. To the 
author’s knowledge, all machine-learning applications of sepsis prediction suffer from non-
generalizable outcomes given limited scope in data sourcing. Populations are often limited to a 
specific, sometimes predisposed subset of patients whose incidences of disease represent a 
frequency greater than that of the general public. One study by Calvert and colleagues sought 
to establish a generalizable machine learning diagnostic tool for sepsis, conceding the same in 
their methodology (Calvert, Saber, Hoffman, & Das, 2019). An improved understanding that 
there exist heterogenous manifestations of sepsis has meant that the simple, clear-cut 
definition as conceived by past consensus conferences may not be attainable. Consequently, 




 The data used for this study were procured from an online repository of clinical trial 
data and required preprocessing and feature selection prior to predictive modeling. 
 
2.1 DATA SOURCE 
The investigation and efficacy of new medical interventions is logged and evaluated by 
execution of randomized clinical trials, the results of which are added to a repository of clinical 
trial data in clinicaltrials.gov on completion. Because clinical trials represent new and 
exploratory analyses on the viability of specific medical interventions there exists an element of 
risk in their execution. Such risk often manifests in the form of adverse events.  
To assess the frequency of target adverse events across multiple clinical trials and to 
leverage machine learning capability to the data, reformatting into a standardized, numerically 
indexed scale was required. The LibSVM format is a vectorized representation of data assigning 
discrete index keys to unique features, and integer, float, or Boolean values representing those 
features. It is this standardization that potentiates subsequent cross-trial study, given the 
machine-readable format that it creates. Thanks to this format standardization executed by 
Tong and colleagues, 30,915 clinical trials were compared with 128,799 unique features 
between them (Tong et al., 2019). Said features belonged to six separate categories: participant 
information (discrete values), trial phase (discrete values), serious adverse event 
(binary/Boolean), other adverse event (binary/Boolean), preexisting condition 
(binary/Boolean), and interventions (binary/Boolean).  
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2.2 DATA TRANSFORMATION AND PREPROCESSING 
Prior to employment of any machine learning methods, the vectorized data required 
significant cleaning and preprocessing. Though standardized across multiple clinical trials, the 
data required further attention for several reasons.  
First, all features involving sepsis required removal from the feature space of the data to 
properly generate target labels denoted by the presence (1) or absence (0) of sepsis outcomes 
from that clinical trial. A corresponding dataset of feature headers was used to produce a list of 
sepsis feature headers whose index numbers were referenced and removed while parsing the 
data.  
Second, extraneous features required removal; said features included the clinical trial 
ID, number of participants, participant median age, total serious adverse events (n=30915), and 
total, other adverse events (n=30915). The former three features were continuous; the aim of 
the study was to consider binary/Boolean “presence” or “absence” of features as predictors. 
The latter two features existed in every clinical trial; the information gained from their inclusion 
was zero, due to zero variance within each respective feature. None of these features would be 
useful since the aim of this study was to determine predictive power of factors for sepsis events 
in a clinical trial context.  
Third, prior to model-fitting, the dataset was a textbook case of the so-called “curse of 
dimensionality” due to its large feature space volume and large ratio of features to rows. Such 
quantity of features almost certainly makes for model overfitting, rendering outcomes devoid 
of any clinical significance or meaning. A few methods were investigated and used to lower 
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chances of over- and under-fitting, namely methods belonging to the families of feature 
selection, and feature dimensionality reduction alongside regularization. 
Below are the raw data as they were received following normalization into this sparse 
vector format: 
 
Figure 2. Raw Sparse Data 
A separate table mapping each clinical trial feature to a key/index was referenced to search the 
raw data for features related to sepsis, but excluding “aseptic”:  
 
 
Figure 3. Feature Headers 
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The following figure is the Python code used to reformat the raw data by excluding sepsis 





















2.3. FEATURE SELECTION 
Feature selection was important in the case of this study because of the high 
dimensionality of the feature space (n=128,799) with respect to the number of clinical trials 
(n=30,915). To that end, filter feature selection methods were used. Wrapper methods were 
considered, but high feature dimensionality can often render wrapper methods subject to 
overfitting (Ciortan, 2019). In addition, filter methods were selected as an attempt at pre-
modelling data standardization; performance could be based solely on the model, and not on 
any embedded feature selection parameters within each model. Feature selection helps 
mitigate issues of overfitting and underfitting the data. Absent feature selection, models may 
learn the variability in the data too well and consequently overoptimize parameters to fit with 
the training data only, thus overfitting the model. Conversely, models may be vulnerable to 
underfitting the data (as is the case with features with low variance). This give-and-take 
between balancing underfitting (low variance, high bias) and overfitting (high variance, low 
bias) is the root conflict of the bias-variance-tradeoff. 
It should be added that prior to feature selection data are often normalized when the 
numeric scales between each of the feature columns differ. Data normalization is useful when 
dealing with continuous features, each with their own distinct numeric ranges. Because all 
features in the selected feature space were binary (either 0, indicative of “absent”, or 1, 





2.3.1 Variance-Based Feature Selection: 
The removal of features with low variance is a necessary step in cleaning the data for 
successful modeling results. Intuitively, if there exists low variance in features, there exists high 
similarity among the instances of said features. If a single feature has the same value across 
many clinical trial instances, the model will learn from these features, to the extent that it 
underfits the model. The scikit-learn feature_selection module and its 
VarianceThreshold method were used to remove all features with zero variance. This 
method uses a default of 0; thus all features that appeared the same across all 30915 clinical 
trials were removed. Subsequent retroactive selection of variance thresholds was performed 
following model execution, and a minimum threshold of variance = 0.01, or 1% (preserving 99% 
of all variance of the dataset), was ultimately selected. This narrowed the feature space from 
128,799 to 754.  
 
2.3.2 Correlation-Based Feature Selection: 
 Correlation-based feature selection operates on the assumption that “a good feature 
subset is one that contains features highly correlated with (predictive of) the class, yet 
uncorrelated with (not predictive of) each other” (Hall, 1999). The challenge with a dataset 
containing semantically different but conceptually similar features (for example, “lesion”, 
“cancer”, “tumor”, “malignant lesion”, etcetera) is to not limit the number of features 
represented in the final model at the expense of feature uniqueness. For this reason, 
correlation-based feature selection was used to further select features in the top 20% of f-
statistics derived from the ANOVA F-test, implemented by the scikit-learn f_classif method 
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from the ‘feature_selection’ module. This method returns features’ respective F-Statistics and 
p-values, or the probability that the null hypothesis is true. In other words, p-values are used to 
determine if mean feature values across positive and negative classes are equal, or, that a 
feature’s presence is independent of the target class. On running the f_classif method on 
the 754 variance-selected features, 306 had p-values of zero. It should be mentioned, however, 
that all but 13 features had p-values greater than 1%; thus exclusive reliance on p-values for 
feature importance measurement would have been fallacious.  On identifying an f statistic 
threshold of 20% the correlation-based method selected the final 151 features to be used in 
model training. These final 151 features were most correlated with sepsis, in that they had the 
highest ANOVA F-test statistics among the features. Below are the top 10 features as ranked by 
their f-statistics: 
Table 3. Features and F-Statistics 
Name F-Statistic 
Phase 2/3 11828.65 
Pyrexia 9821.41 
Pneumonia 9665.61 
Myocardial Infarction 8926.04 
Cellulitis 8876.59 
Atrial Fibrillation 8605.05 
Chest Pain 8215.73 
Dehydration 7857.79 
Back Pain 7687.53 
Anemia 7634.04 
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2.4 DIMENSIONALITY REDUCTION 
It should be mentioned that feature selection and dimensionality reduction, though 
both filtering down the number of features, are two distinct operations. Whereas feature 
selection excludes selected features from models without changing those features, 
dimensionality reduction transforms features into a lower dimensional space, by which feature 
selection automatically follows.   
 
2.4.1 Truncated SVD: 
 Truncated Singular Value Decomposition (SVD) were initially pursued as an attempt at 
dimensionality reduction. However, given that the objective of this study was to examine and 
evaluate discrete clinical trial features as individual predictors of sepsis, and given that 
truncated SVD consolidates related feature vectors into a summed eigenvector, an implicit loss 
in granularity of features would have occurred. Moreover, since truncated SVD outputs a 
predetermined number of vectors, all of which represent generalized eigenvalues of clinical 
categories, the clinical usefulness of such an output would be difficult to argue in the context of 
this study. Clinicians are already aware of broad domain-specific covariates of sepsis. The aim 
here, was to attempt to identify more specific outputs/features.  
The output of truncated SVD is graphically represented in a generic, oversimplified form 
for four model principal components. To note, superscripts indicate correlation with the base 
feature (such that AE and EA communicate some degree of similarity between features A and E). 
In this simplified diagram, red vectors represent the sum (a principal component) of two 









Figure 6. Simplified linear algebra of the Truncated SVD algorithm 
 
Truncated SVD operates on the principle that, in a vector space, a linear map (or a 
matrix) is a combination of rotated, reflected, scaled, and killed (scaling by 0) vectors. This holds 
so long as the axes defining that vector space are valid. SVD is a technique leveraging matrix 
factorization by synthesizing three child matrices from a matrix. (Charan, 2020) 
More specifically, if A is a matrix, or linear map, from an n-dimensional vector space V to 
an m-dimensional vector space W, then A can be considered a product of 3 other matrices, R, 
D, and S. Here S is an “n x n” rotational matrix with source and target both V; D is an “m x n” 
diagonal matrix with source V and target W: only non-zero entries are on the diagonal; R is an 
“m x m” rotational matrix with source W and target W.  
First vectors in space V are rotated using S. Second those same vectors are scaled by 
some constant, and inputted into W by using axes from the map, A. Finally, those output 
vectors are rotated in W using the R rotational matrix. (Charan, 2020) 
 
                  AE 
                  BG 
                  CD 
                  DC 
                  EA 
                  FH 
                  GB 















Vdim=n                  Wdim=m 
A = R*D*S 
𝐴 =  𝑆: [
𝑠1 𝑠2
𝑠3 𝑠4









Figure 7. Simplified Truncated SVD Component Vector Addition 
(Charan, 2020) 
The SVD technique is similar to another dimensionality reduction technique called 
Principal Component Analysis (PCA); however, the former operates on raw data matrices, while 
the latter operates on a covariance matrix (Avila & Hauck, 2017). The incompatibility of PCA 
with sparse data stems from the fact that it requires operation on an entire matrix (via 
calculation of a covariance matrix), whereas SVD does not. 
Truncated SVD could be useful in subsequent studies to determine organ-system-
specific predictors for different pathobiologies of sepsis. However, for the purposes of this 




2.5 CROSS VALIDATION 
 Cross validation is typically most useful for datasets with limited numbers of 
observations (Avila & Hauck, 2017). One type of cross validation called k-fold cross validation 
splits training data into a selected number of equally distributed parts, or folds, assigning one of 
the folds as a holdout, or test set; the remaining k – 1 folds are used to train the model. For 
example, a k-fold cross-validation where k = 100 is a 100-fold cross validation. The model will be 
iteratively trained using each of the 99 training folds and will test the accuracy of the model by 
feeding it the hold-out set. Outputted from a 100-fold cross validation model evaluation are 
100 k scores, which are averaged, and represent the mean model performance. (Kelleher, 
Namee, & D’Arcy, 2015) 
 
Figure 8. K-fold Cross-Validation 
(Kong, 2017) 
Given the size of the dataset and given the low computational cost of using the built-in 
train_test_split method of the model_selection module, cross validation was 
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considered but not pursued. This module randomly partitions arrays and/or matrices into 
training and testing folds of the original dataset. In the case of both the logistic regression 
baseline model (nfeatures = 128,799) and the feature-selected logistic regression model 
(nfeatures=151), 10-fold cross validation was performed on the dataset. In comparing cross-
validated performance with train_test_split performance, no statistically significant 
advantage in the form of better performance was observed in using the former over the latter.  
 
2.6 MODELS 
There is a phrase in data science and machine learning that there is “no free lunch when 
it comes to model selection”; there is no single model that unilaterally performs better across 
all instances (said instances being data inputs and desired outputs) (Fermin, 2019). Because of 
this, a number of models were chosen to determine the predictive power of the cleaned clinical 
trial data. These included logistic regression, support vector machines (SVM) with using linear, 
polynomial, sigmoidal, and radial basis function (RBF) kernels, naïve Bayes classifier, decision 
trees, and ensembles of decision trees called random forests. classes.  
Following model prediction on subsets of testing data, cross-model performance was 
evaluated to ultimately select the best-performing model. It should also be added that each of 
these models belonged to the family of supervised machine-learning classifiers: supervised 
because the features and classes were labeled; classifiers because the object is to determine 
predictive power of datasets with feature labels, and subsequently evaluate and classify the 
predictive power of each feature.   
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2.6.1 Logistic Regression 
 Logistic regression (LR) is a binary classification algorithm that assigns a class to a 
categorical feature via application of a 50% probability (Geron, 2019). LR calculates the 
weighted sum of the entire input feature space and outputs its biased logistic, scaled between 0 
and 1, where an output greater than 0.50 indicates positive association with the target variable, 
and an outcome less than 0.50 indicates a negative association with the target variable. More 





or graphically represented: 
 
Figure 9. Sigmoid Function 
(sklearn.linear_model.LogisticRegression, 2020) 
Within this scale [0.0, 1.0], all logistic regression models estimate probabilities that some 
feature/instance belongs to a class, or that: 
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?̂? = ℎ𝜃(x) 
Where ?̂? equals the calculated probability that the instance, x, belongs to the category, ℎ𝜃. In 
the context of this case study: 
?̂? = {
0 𝑖𝑓 ?̂?  < 0.5
1 𝑖𝑓 ?̂?  ≥ 0.5
 that a feature is consistent with sepsis 
   
where ?̂? is the classification produced by the model. Thus it stands to reason that if an 
estimated probability that a feature belongs to the sepsis class equals 0.6, there is a 60% 
chance that a feature will predict sepsis. 
 Though logistic regression produces such probabilities according to this non-linear 
sigmoidal function, it is still considered a linear model because on solving σ(x) = 
1
(1+𝑒−𝑥)
 for x, 





  (𝑠𝑖𝑔𝑚𝑜𝑖𝑑 𝑓𝑢𝑛𝑐𝑡𝑖𝑜𝑛) 




𝑒−𝑋 =  
1
𝑝












𝑋 =  log 
𝑝
𝑞
  (𝑙𝑜𝑔𝑖𝑡 𝑓𝑢𝑛𝑐𝑡𝑖𝑜𝑛) 
(Klosterman, 2019) 
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the resulting equation for the log odds, or odds ratio, represents a probability given a linear 
combination of all features in the feature space. Thus, because X, or the aggregate linear 
combination of features when the response variable equals the logit function, logistic 




    (sigmoidal logistic regression) 
𝜃0 + 𝜃1𝑋1 + 𝜃2𝑋2 + ⋯ 𝜃𝑛𝑋𝑛 = log 
𝑝
𝑞
 (log odds logistic regression) 
Because the sigmoid equation can be unilaterally generalized with such a transformation into 
the logit function, or, into a 𝑦 = 𝑚𝑥 + 𝑏 form, it is proven that logistic regression is linear. 
(Klosterman, 2019) 
2.6.1.1 REGULARIZATION 
Lasso and Ridge regularization methods are two methods that assign penalty, or cost, 
for having larger coefficients in a fitted model. In short, these methods assign cost, or penalties 
for predicting values incorrectly, and in doing so are integral in parameter optimization for 
returning the least “costly” model. By doing this, the model learns from an inputted training set 
of data for model fitting that can generalize to new data on being asked to predict outcomes.  
The log-loss function is one such cost function used in scikit-learn for penalty assignment and 
model fitting in a number of models, but most notably logistic regression: 






∙ log(𝑝𝑖)) + (1 − 𝑦𝑖) ∙  log (1 − 𝑝(𝑦𝑖)) 
(Klosterman, 2019) 
 
where n is equal to the number of samples, 𝑦𝑖 is equal to the actual label of a sample of index, I, 
and 𝑝𝑖 is the probability that a sample at index I belongs to the target class (or 𝑝(𝑦𝑖) = 1). By 
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optimizing model parameters, the response variable log odds and individual features’ log odds 
are calibrated to the other to minimize the cost function. Log loss is also called the cross-
entropy function, or simply the “difference between two probability distributions for a given 
random variable or set of events” (Brownlee, 2019). 
 Two extrapolations on the log loss function are lasso (L1) and ridge (L2) regularization 
methods. Both methods leverage the log loss function, but each use a different term to 
minimize the cost function. The L1 regularization appends the log loss with the 1-norm: 









∙ log(𝑝𝑖)) + (1 − 𝑦𝑖) ∙ log(1 − 𝑝(𝑦𝑖)) 
 
 
and the L2 regularization appends the log loss with the 2-norm. 










∙ log(𝑝𝑖)) + (1 − 𝑦𝑖) ∙ log(1 − 𝑝(𝑦𝑖)) 
(Klosterman, 2019) 
 
Except for the operations performed by the first term, the two regularization models are 
identical. The key difference is that L1 includes the sum of absolute values of coefficients 
between m different features, whereas L2 includes the sum of squares. With respect to 
performance, L1 can be used as a feature selection method if given a coefficient equal to 
exactly zero, as this assignment eliminates the feature. L2 penalties do not eliminate features 
given a coefficient value of zero. 
In the case of this study, binary logistic regression was used, given that the response 
variable accounted for two possible outcomes: sepsis, and not sepsis. Within the 
LogisticRegression method, cost penalties L1 or L2 are specified. 
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2.6.1.2. Solvers 
The LogisticRegression method also accepts a solver parameter. Solvers find 
parameter weights for further minimizing the cost function, previously specified. Used in this 
study were liblinear, sag, and saga solvers. 
The liblinear solver minimizes the cost function from a single direction at a time; given 
this detail, logistic regression with this solver performed noticeably slower than the same 
models using gradient descent. Sag, or the stochastic average gradient descent solver, 
abbreviates parameter calculation by randomly sampling in-cache gradient values, but is limited 
to L2 regularization. Saga is a variant of Sag, but instead is compatible with L1 regularization, 
which allows for input of sparse data. Both the sag and saga solvers are optimized for larger 
datasets. (sklearn.linear_model.LogisticRegression, 2020) 
 
2.6.2 Support Vector Machine (SVM) 
 Support vector machines (SVM) are another form of classification algorithm but do not 
require linearity for classification. SVMs determine and optimize two-, three-, or multi-
dimensional hyperplanes as modes of classification, as well as decision boundaries in cases 
where data points are not unilaterally/linearly separable. Ultimately SVM aims to separate 
datapoints by some maximum distance from a hyperplane called a margin (Kelleher, Namee, & 
D’Arcy, 2015). The support vectors are those datapoints.  
In cases where separability is indeed not linear, additional functions called kernels are 
applied for decision function specification. Kernels ultimately act as operators that apply some 
weight to the data, transforming the distances between datapoints in the aggregate so a 
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hyperplane is more easily found. Weights may be unilaterally applied (linear) or nonlinear, 
depending on the kernel function. This is simplified for the sake of exposition below, where a 
two-dimensional feature space (where data are non-linearly separable via hyperplane) is 
kernelized, or projected, into a three-dimensional feature space (where data are linearly 
separable via a hyperplane with maximum margin): 
(Fletcher, 2009) 
Figure 10. Kernel Trick for Hyperplane Identification 
Kernels provided by sklearn include a linear, polynomial, radial basis function (RBF), or 




Figure 11. Various SVM Kernel Applications on Iris Dataset 
(sklearn.svm.LinearSVC, 2020) 
2.6.2.1 Linear Kernel 
 The linear kernel in a support vector machine is used when data is linearly separable. 
This kernel is most typically used when the data have many features and two classes, making 
this kernel ideal for the dimensions of the dataset. A linear hyperplane can be a line in two 
dimensions, or a plane in three dimensions, and can be represented in a standard 𝑦 = 𝑚𝑥 + 𝑏 
format, with dimensions as parameters: 




2.6.2.2. Radial Basis Function Kernel  
 The Radial Basis Function (RBF) kernel is a kernel used under similar circumstances to 
the linear kernel, but instead takes Euclidean distance between data points into account. The 
RBF Gaussian kernel is as follows: 
𝑘𝐺(𝑥, 𝑥




where σ equals a parameter, and d is the Euclidean Distance (or direct-line distance) between 
the two data points x and x’ (Vert, Tsuda, & Schölkopf, 2004). 
 
2.6.3 Naïve Bayes 
 Naïve Bayes classification is another classification algorithm that naively assumes 





As an example applied to the context of this study, if sepsis is related to blood pressure, then, 
using Bayes’ theorem, a person's blood pressure can be used to more accurately assess the 
probability that they have sepsis than can be done without knowledge of the person’s blood 
pressure.  
 A Naïve Bayes assumption states that features are conditionally independent of each 
other given some response variable. Or: 
𝑃(𝑋1|𝑋2, 𝑌) = 𝑃(𝑋1|𝑌) 
or in the case of the 151 features from the dataset: 
34 
P(Sepsis|X1,X2,…,X151) 
and applied to Bayes’ Theorem: 
𝑃(𝑠𝑒𝑝𝑠𝑖𝑠|𝑋1, … , 𝑋151) =
𝑃(𝑋1|𝑠𝑒𝑝𝑠𝑖𝑠)𝑃(𝑋2|𝑠𝑒𝑝𝑠𝑖𝑠) …  𝑃(𝑋151|𝑠𝑒𝑝𝑠𝑖𝑠)𝑃(𝑠𝑒𝑝𝑠𝑖𝑠)
𝑃(𝑋1)𝑃(𝑋2) … 𝑃(𝑋151)
 
The denominator remains unchanged and can thus be eliminated when determining class 
outcome: 
𝑃(𝑠𝑒𝑝𝑠𝑖𝑠|𝑋1, … , 𝑋151)  ∝  𝑃(𝑋1|𝑠𝑒𝑝𝑠𝑖𝑠)𝑃(𝑋2|𝑠𝑒𝑝𝑠𝑖𝑠) …  𝑃(𝑋151|𝑠𝑒𝑝𝑠𝑖𝑠)𝑃(𝑠𝑒𝑝𝑠𝑖𝑠) 
Then, given predictors, Sepsis can be identified: 




Naïve Bayes classifiers uses maximum likelihood estimation for parameter estimation, taking 
into account conditional probability and prior probability. There exist multiple types of Naïve 
Bayes classifier. The two used in this study included Bernoulli and Gaussian Naïve Bayes. The 
former uses Boolean features for class prediction (0 and 1), and the latter uses continuous 
features. 
 
2.6.4 Decision Tree 
 Decision trees are recursive decision structures that seek to maximize quantifiable 
information gain by identifying the most informative feature for each node and applying 
subsequent decision splits to each subsequent feature. These algorithms are instantiated at an 
aggregate “bin” of all possible features, called a root node, representative of the population 
being sorted. Each subsequent decision point below the root node is called a node, and final 




Figure 12. Decision tree: unpruned 
Decision trees are among the most popular machine learning algorithms because they 
are almost immediately interpretable both in rationale and practice; the issue of the machine 
learning “black-box” is less likely to apply to decision trees. Additionally, they are capable of 
both regression and classification tasks (predicated on whether the machine learning problem 
is concerned with continuous or categorical features), making them versatile and good baseline 
models against which to compare other non-tree-based models or ensemble tree models.  
Decision splits are determined by a number of different decision rules, but in the case of  
this study were Entropy and Gini rules. The former determines the variety of possibilities, or 
disorder, of a target variable. The latter is a measure of the impurity, or the rate at which a 
randomly chosen feature predicts the wrong class. 
A few popular decision trees algorithms include the Iterative Dichotomizer 3 (ID3), CART 
(Classification and Regression Trees), CHAID (Chi-squared Automatic Interaction Detection for 
classification tasks). A number of derivative machine learning algorithms have come from 
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decision tree classifiers including fast and frugal trees (minimally deep/maximally shallow 
decision trees designed to aid decision flows in professional spaces where the bulk of decision-
making can be distilled down to a few crucial steps), and extrapolative bootstrapping models 
like random forests and gradient boosted decision trees. 
Decision trees are at a disadvantage when used on their own or when working with data 
of high dimensionality. If not for the feature selection and engineering methods employed, the 
high variance of the data would have caused a non-generalizable model. Despite this, a decision 
tree model was applied to the dataset for the sake of exposition re: the continuum of tree-
based classifiers ranging from decision trees to random forest classifiers (and perhaps in 
subsequent study, gradient boosted tree algorithms) and its clear representation of knowledge.   
 
2.6.5. Random Forests 
Random forests bagging ensembles, or collections/forests of decision trees that have 
been bootstrapped. Bootstrapping is the process of resampling the training dataset in parallel 
with model fitting and replacing poorly performing samples. Bootstrapping aggregates all these 
inputs via a number of different techniques, but sklearn compiles a list of all predicted 
probabilities for each feature, selecting the feature with the highest probability as an output. 
On generating some specified number of decision trees with the n_estimators parameter, 
trees are averaged, and a prediction is outputted (sklearn, 2020).  
Random forests are greater than the sum of their parts, in that their strength lies in the 
numbers of their constituents. Outputs are committee-based and represent a collective 




 The objectives of the study were three-fold. First, the study was a practice in data 
manipulation and reformatting, which required in-depth understanding of data structures and 
data types. Before the data were ready for machine learning, there existed multiple indexed 
sepsis events that required removal from the feature space, but whose presence or absence 
required denoting. 
Second, this thesis represented an introduction to medically applied machine learning as 
well as feature and model selection.  
Third, this thesis aimed to contribute to two conversations. The first, that the 
continued/further integration of machine learning applications into the clinical space could 
supplement modern evidence-based medicine best-practices for disease diagnosis, prediction, 
and prevention/intervention, thus potentiating maximal health outcomes. The second, that a  
new sepsis definition should be pursued, ought to incorporate machine learning into its 
underlying framework, and should require explicit diagnostic criteria including covariates of 
disease, rather than settling on ED/ICU-gathered prognosis outcomes self-described as markers 
for diagnosis. It is reiterated that use of prognostics as diagnostics for sepsis is dangerous, 








Table 4. Optimized Model Results Table 
 
Algorithm Tags 
Feature Selected Model 
Precision Recall F1-Score  AUROC Accuracy 
Logit 
No Sepsis 0.94 0.97 0.95 
0.79 0.92 
Sepsis 0.77 0.61 0.68 
SVM 
No Sepsis 0.94 0.97 0.95 
0.78 0.92 
Sepsis 0.78 0.58 0.67 
Naïve Bayes 
No Sepsis 0.95 0.91 0.93 
0.83 0.86 
Sepsis 0.56 0.71 0.62 
Decision Tree 
No Sepsis 0.92 0.97 0.94 
0.73 0.91 
Sepsis 0.71 0.51 0.59 
Random 
Forest 
No Sepsis 0.93 0.97 0.95 
0.78 0.92 
Sepsis 0.76 0.72 0.74 
 
  
 TP = True Positive 
 TN = True Negatives  
 FP = False Positive 














    
 





 The results table includes precision, recall and f1 scores for each of the feature-selected 
selected models. The random forest model performed best and identified phase 2/phase 3, 
phase 3/phase 4, sleep apnea syndrome, deep vein thrombosis, dyspnea, atrial Fibrillation, 
chronic obstructive pulmonary disease, cancer pain, acute cholecystitis, peritonsillar abscess as 
the top ten most predictive features.  
 The best performing models are summarized with the following AURCOCs, and 
normalized/non-normalized confusion matrices. 
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4.1. Logistic Regression: Sag Solver 
 
Figure 13. AUCROC For Logistic Regression Sag Solver  
 
 Figure 14. Logistic Regression Sag Solver Confusion Matrix 
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Figure 15. Normalized Confusion Matrix for Sag Solver
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4.2. Support Vector Machines: Linear Kernel 
 
 Figure 16. AUCROC for SVM.SVC Linear Kernel 
 






















4.3. Naïve Bayes Classifier: Gaussian Classifier 
 
 Figure 19. AUCROC For Naïve Bayes Gaussian Classifier 
 
 
 Figure 20. Naïve Bayes Gaussian Classifier Confusion Matrix 
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4.4 Decision Tree: Gini Depth 10 
 
 Figure 22. AURCOC for Gini Impurity Depth 10 Decision Tree 
 











4.5. Random Forest: Gini Impurity 
 
 Figure 25. AUROC for Random Forest Gini Impurity  
 
 Figure 26. Random Forest Gini Impurity Confusion Matrix 
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Given that only 4,367 of the 30,915 (14%) of clinical trials reported any incidences of 
sepsis, the issue of class imbalance was significant. In machine learning, the most accurate 
models are those trained on data with classes that are near equal in distribution. In the case of 
binary response variables (0 for no sepsis, 1 for sepsis), this optimal distribution would have 
had 15,458 incidences each of sepsis and no sepsis. 
Accuracy scores were likely bloated due to class imbalance as well. Moreover, an over-
reliance on accuracy as a robust assessment of the models’ performances in the instance of this 
dataset would be misleading. Because models predict both sepsis-related (1) and non-sepsis-
related (0) events, and because the ratio of non-sepsis:sepsis in the data is roughly 7:1, 
accuracy figures are too heavily influenced by the models’ specificities (true negative rate). The 
same weight is being given to specificity as sensitivity, despite the class imbalance.  
A subsequent study could work to further improve preprocessing steps to target a 1:1 
ratio class events using a technique called the Synthetic Minority Over-sampling Technique, or 
SMOTE (Chawla, Bowyer, Hall, & Kegelmeyer, 2002). This method synthetically generates new 
samples consistent with the minority class distribution and is available in the 
imbalanced_learn library’s SMOTE class. Further investigation into boosted ensemble 
classifiers like gradient boosted trees/models, Adaboost, or XGBoost could be a means of 
applying the subject matter of this study to more relevant and modern models.  
Finally, as the title suggests, the approach to sepsis classification is naïve, in that sepsis 
events are lumped into a single feature. Given that that modern understanding of the 
pathobiology and pathophysiology of sepsis suggests its mechanism may be organ-system 
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specific, the follow-up study could assign nominal or ordinal categories to different sepsis 
categories. 





The healthcare industry is experiencing a paradigm shift in how it identifies, describes, 
predicts, intervenes, and prevents major adverse health outcomes thanks in large part to 
machine learning models. Constant revision of modern machine learning techniques guarantees 
improved results. When applied to healthcare, such improved results are assumedly countless.  
It is difficult to conceive of a future where machine learning will not continue to impact 
healthcare, if not already doing so. Machine learning is becoming increasingly common in the 
healthcare data space including but not limited to: clinical decision support tools; health vitals 
analytics and prediction made possible by data generation and aggregation from wearable 
health devices, electronic health record data, and insurance health claims data; image 
processing of medical images for early detection of disease; pharmaceutical development and 
design via machine learning aided discovery of prognostic biomarkers (Vamathevan et al., 
2019); and this list continues to grow.   
In this study a suite of models was used to identify predictors of sepsis from 128,799 
features distributed among 30,915 unique clinical trials. Thanks to the open-source nature of 
machine learning libraries like scikit-learn, and a readiness by the data science and machine 
learning community for knowledge transfer, this project has been an illuminating practice in 
machine learning applications and platforms for discourse. Though there is no turnkey solution 
for health outcome maximization, artificial intelligence and machine learning represent a 
tinkerer’s paradise for iterative learning and hypothesis testing that can only make a future 
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